ENDRA Life Sciences Inc. Common Stock

NDRANASDAQUSD
4.42 USD
0.20 (4.72%)🟢PRE MARKET (AS OF 09:17 AM EDT)
🟢Market: OPEN

Shares of ENDRA Life Sciences Inc. Common Stock (NDRA) are trading at $4.42. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest NDRA is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Aug 4, 2026.

Open?$4.31
High?$4.42
Low?$4.31
Prev. Close?$4.22
Volume?7
Avg. Volume?47.1K
VWAP?$4.39
Rel. Volume?0.00x
Bid / Ask
Bid?$2.83 × 100
Ask?$5.03 × 100
Spread?$2.20
Midpoint?$3.93
Valuation & Ratios
Market Cap?5.4M
Shares Out?1.3M
Float?1.2M
Float %?94.3%
P/E Ratio?N/A
P/B Ratio?3.00
EPS?-$5.75
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
Employees
11
Market Cap
5.3M
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed
2017-06-28
Address
3600 GREEN COURT
ANN ARBOR, MI 48105
Phone: 734-335-0468
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-49.88Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.36%Low
Short Interest?27.6K
Days to Cover?1.0
Free Float1.2M
Avg Daily Volume36.8K
Settlement Date2026-07-15
Financial Health
Current Ratio?0.64Weak
Quick Ratio?0.64Weak
Cash Ratio?0.43Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
56
3.00CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.8CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-408.7%WEAK
ROA?
S&P
3
-212.4%WEAK
Cash Flow & Enterprise
FCF?$-5009079
Enterprise Value?$5.0M
Fundamentals ratios updated end of day